SEI Trust Company’s BioMarin Pharmaceuticals BMRN Stock Holding History

SEI Trust Company’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$1.59M	Buy	22,097 +11,427	+107%	+$751K	0.02%	739
2014 Q2	$664K	Sell	10,670 -301,490	-97%	-$18.2M	0.01%	1021
2014 Q1	$21.3M	Buy	312,160 +124,480	+66%	+$9.17M	0.21%	130
2013 Q4	$13.2M	Buy	187,680 +38,695	+26%	+$2.63M	0.13%	193
2013 Q3	$10.8M	Buy	148,985 +22,695	+18%	+$1.51M	0.12%	210
2013 Q2	$7.05M	Buy	+126,290	New	+$7.87M	0.09%	257

Other funds holding BMRN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SEI Trust Company's BMRN Position: Q3 2014 in Review

SEI Trust Company increased its BioMarin Pharmaceuticals (BMRN) stake by 107% in Q3 2014, buying an estimated $751K and bringing the position to 22,097 shares worth $1.59M. The position accounts for 0.02% of the portfolio, ranked #739.

SEI Trust Company first reported a position in BMRN in Q2 2013 and has held it in 6 quarters since. The position peaked at $21.3M in Q1 2014. 317 funds tracked by Wall St. Rank hold BMRN as of Q3 2014.

SEI Trust Company held 22,097 shares of BioMarin Pharmaceuticals worth $1.59M as of Q3 2014.
SEI Trust Company bought 11,427 BioMarin Pharmaceuticals shares in Q3 2014, an estimated $751K.
BioMarin Pharmaceuticals made up 0.02% of SEI Trust Company's portfolio in Q3 2014, its #739 holding.
SEI Trust Company first reported a position in BioMarin Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
SEI Trust Company's BioMarin Pharmaceuticals position peaked at $21.3M in Q1 2014.
317 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2014.

Based on SEI Trust Company's 13F filing for Q3 2014, filed 28 Oct 2014.